The results demonstrated anti-tumor immunity of oncolytic viruses and indicated strong efficacy of the viruses against solid tumor cancers. Untill now 200 patients have been treated with oncolytic
Antares Pharma’s subcutaneous and intramuscular injection technology platforms include Vibex disposable pressure-assisted auto injectors, Valeo/Vision reusable needle-free injectors, and disposable multi-use pen injectors. The payment was related to
Vaxon Biotech said that the Phase I/II trial was conducted among 116 patients with different types of cancer including 33 patients with NSCLC. The primary objective was to
Horizon Pharma said that the MONA (modified release prednisone for the treatment of nocturnal asthma) study is a two-stage, open-label, pilot trial assessing Lodotra’s treatment effect in patients
Christian Behrenbruch, CEO of ImaginAb, said: “ImaginAb is pleased to have formalised this collaboration with the GSK CIC. Not only does GSK have an excellent biologics pipeline, but
Allergan claimed that Zymaxid is now the highest concentration gatifloxacin ophthalmic solution on the market in the US. Zymaxid contains 0.5% gatifloxacin, a topical fluoroquinolone, and is formulated
Movianto is part of the Celesio, a healthcare distribution group. The group is active in 26 countries and employs more than 46,000 people in its three divisions patient
InVasc Therapeutics said that one grant is to continue research and development of small molecule drugs for the prevention and treatment of hypertension and stroke based on derivatives
The data were presented at the American Thoracic Society 2010 International Conference in New Orleans, LA by Geron collaborator Claude Jourdan Le Saux from the University of Texas
Heska claimed that the VitalPath analyzer delivers accurate results in just 50 seconds for blood gases, electrolytes, and hematocrit, as well as 27 additional calculated parameters. Requiring just
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.